Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 517
Filtrer
1.
Ann Neurol ; 79(6): 1000-13, 2016 06.
Article de Anglais | MEDLINE | ID: mdl-27091721

RÉSUMÉ

OBJECTIVE: Chronic migraine (CM) is often associated with chronic tenderness of pericranial muscles. A distinct increase in muscle tenderness prior to onset of occipital headache that eventually progresses into a full-blown migraine attack is common. This experience raises the possibility that some CM attacks originate outside the cranium. The objective of this study was to determine whether there are extracranial pathophysiologies in these headaches. METHODS: We biopsied and measured the expression of gene transcripts (mRNA) encoding proteins that play roles in immune and inflammatory responses in affected (ie, where the head hurts) calvarial periosteum of (1) patients whose CMs are associated with muscle tenderness and (2) patients with no history of headache. RESULTS: Expression of proinflammatory genes (eg, CCL8, TLR2) in the calvarial periosteum significantly increased in CM patients attesting to muscle tenderness, whereas expression of genes that suppress inflammation and immune cell differentiation (eg, IL10RA, CSF1R) decreased. INTERPRETATION: Because the upregulated genes were linked to activation of white blood cells, production of cytokines, and inhibition of NF-κB, and the downregulated genes were linked to prevention of macrophage activation and cell lysis, we suggest that the molecular environment surrounding periosteal pain fibers is inflamed and in turn activates trigeminovascular nociceptors that reach the affected periosteum through suture branches of intracranial meningeal nociceptors and/or somatic branches of the occipital nerve. This study provides the first set of evidence for localized extracranial pathophysiology in CM. Ann Neurol 2016;79:1000-1013.


Sujet(s)
Inflammation/génétique , Migraines/génétique , Périoste/métabolisme , Adolescent , Adulte , Sujet âgé , Marqueurs biologiques/métabolisme , Études cas-témoins , Céfaloridine/pharmacologie , Maladie chronique , Jeûne , Femelle , Expression des gènes/effets des médicaments et des substances chimiques , Analyse de profil d'expression de gènes/méthodes , Humains , Isoflurane/pharmacologie , Lectines de type C/génétique , Lévodopa/pharmacologie , Mâle , Adulte d'âge moyen , Inhibiteur alpha de NF-KappaB/génétique , Récepteurs immunologiques/génétique , Récepteur à l'interleukine-1 de type II/génétique , Protéine-3 induite par le facteur de nécrose tumorale alpha/génétique , Jeune adulte
2.
Mol Pharm ; 7(6): 2120-31, 2010 Dec 06.
Article de Anglais | MEDLINE | ID: mdl-20831193

RÉSUMÉ

Organic cation/carnitine transporter (OCTN2; SLC22A5) is an important transporter for L-carnitine homeostasis, but can be inhibited by drugs, which may cause L-carnitine deficiency and possibly other OCTN2-mediated drug-drug interactions. One objective was to develop a quantitative structure-activity relationship (QSAR) of OCTN2 inhibitors, in order to predict and identify other potential OCTN2 inhibitors and infer potential clinical interactions. A second objective was to assess two high renal clearance drugs that interact with OCTN2 in vitro (cetirizine and cephaloridine) for possible OCTN2-mediated drug-drug interactions. Using previously generated in vitro data of 22 drugs, a 3D quantitative pharmacophore model and a Bayesian machine learning model were developed. The four pharmacophore features include two hydrophobic groups, one hydrogen-bond acceptor, and one positive ionizable center. The Bayesian machine learning model was developed using simple interpretable descriptors and function class fingerprints of maximum diameter 6 (FCFP_6). An external test set of 27 molecules, including 15 newly identified OCTN2 inhibitors, and a literature test set of 22 molecules were used to validate both models. The computational models afforded good capability to identify structurally diverse OCTN2 inhibitors, providing a valuable tool to predict new inhibitors efficiently. Inhibition results confirmed our previously observed association between rhabdomyolysis and C(max)/K(i) ratio. The two high renal clearance drugs cetirizine and cephaloridine were found not to be OCTN2 substrates, and their diminished elimination by other drugs is concluded not to be mediated by OCTN2.


Sujet(s)
Céfaloridine/composition chimique , Cétirizine/composition chimique , Transporteurs de cations organiques/composition chimique , Relation quantitative structure-activité , Cellules cultivées , Céfaloridine/pharmacologie , Cétirizine/pharmacologie , Humains , Cinétique , Modèles moléculaires , Simulation de dynamique moléculaire , Structure moléculaire , Transporteurs de cations organiques/antagonistes et inhibiteurs , Membre-5 de la famille-22 de transporteurs de solutés
3.
Cell Biochem Funct ; 26(7): 778-86, 2008 Oct.
Article de Anglais | MEDLINE | ID: mdl-18683897

RÉSUMÉ

Membrane permeability transition (MPT) of mitochondria has an important role in apoptosis of various cells. The classic type of MPT is characterized by increased Ca(2+) transport, membrane depolarization, swelling, and sensitivity to cyclosporin A. In this study, we investigated whether L-carnitine suppresses oleic acid-induced MPT using isolated mitochondria from rat liver. Oleic acid-induced MPT in isolated mitochondria, inhibited endogenous respiration, caused membrane depolarization, and increased large amplitude swelling, and cytochrome c (Cyt. c) release from mitochondria. L-Carnitine was indispensable to beta-oxidation of oleic acid in the mitochondria, and this reaction required ATP and coenzyme A (CoA). In the presence of ATP and CoA, L-carnitine stimulated oleic acid oxidation and suppressed the oleic acid-induced depolarization, swelling, and Cyt. c release. L-Carnitine also contributed to maintaining mitochondrial function, which was decreased by the generation of free fatty acids with the passage of time after isolation. These results suggest that L-carnitine acts to maintain mitochondrial function and suppresses oleic acid-mediated MPT through acceleration of beta-oxidation.


Sujet(s)
Carnitine/pharmacologie , Membranes intracellulaires/effets des médicaments et des substances chimiques , Membranes intracellulaires/métabolisme , Mitochondries du foie/effets des médicaments et des substances chimiques , Acide oléique/pharmacologie , Adénosine triphosphate/pharmacologie , Animaux , Céfaloridine/pharmacologie , Coenzyme A/pharmacologie , Cytochromes c/métabolisme , Mâle , Potentiels de membrane/effets des médicaments et des substances chimiques , Mitochondries du foie/métabolisme , Gonflement mitochondrial/effets des médicaments et des substances chimiques , Phosphorylation oxydative/effets des médicaments et des substances chimiques , Consommation d'oxygène/effets des médicaments et des substances chimiques , Perméabilité/effets des médicaments et des substances chimiques , Agents protecteurs/pharmacologie , Rats , Rat Wistar , Facteurs temps
4.
FEMS Microbiol Lett ; 250(2): 195-200, 2005 Sep 15.
Article de Anglais | MEDLINE | ID: mdl-16099113

RÉSUMÉ

Blocking peptidoglycan synthesis in Escherichia coli with moenomycin or vancomycin led to the accumulation of UDP-MurNAc-pentapeptide and of its immediate upstream precursors, whereas with cephaloridine or penicillin G the pool of UDP-MurNAc-pentapeptide decreased. With MraY and FtsW deficiencies the decrease of UDP-MurNAc-pentapeptide was accompanied by an increase of the upstream nucleotide precursors and the appearance of UDP-MurNAc-tetrapeptide.


Sujet(s)
Antibactériens/pharmacologie , Protéines bactériennes/génétique , Escherichia coli/métabolisme , Protéines membranaires/génétique , Peptidoglycane/métabolisme , Transferases/génétique , Séquence glucidique , Céfaloridine/pharmacologie , Chromatographie en phase liquide à haute performance , Escherichia coli/effets des médicaments et des substances chimiques , Escherichia coli/génétique , Données de séquences moléculaires , Oligosaccharides/pharmacologie , Benzylpénicilline/pharmacologie , Précurseurs de protéines/métabolisme , Transferases (other substituted phosphate groups) , Acide uridine diphosphate N-acétylmuramique/analogues et dérivés , Acide uridine diphosphate N-acétylmuramique/métabolisme , Vancomycine/pharmacologie
5.
J Pharmacol Sci ; 98(1): 49-57, 2005 May.
Article de Anglais | MEDLINE | ID: mdl-15879677

RÉSUMÉ

We have previously reported that the enhancement of free radical generation in mitochondria isolated from the kidney cortex of rats exposed to cephaloridine (CER) is probably mediated by the activation of protein kinase C (PKC). We examined which isoenzymes of PKC might be involved in the development of nephrotoxicity induced by CER in rats. The CER-induced renal dysfunction observed 24 h after its injection was prevented by a potent antioxidant DPPD and well-known PKC inhibitors like H-7 and rottlerin. At 1.5 and 3.5 h after the CER injection, the free radical generation was increased markedly and this was associated with translocation of PKCdelta into the mitochondria of renal cortex tissue. Pretreatment of rats with H-7, a PKC inhibitor, significantly inhibited the CER-derived increase in mitochondrial generation of free radicals, suggesting that H-7 probably gets into the mitochondria and inhibits the activity of translocated PKC within the mitochondria. It was also shown that pretreatment of rats with rottlerin, a specific inhibitor of PKCdelta, suppressed the early translocation of PKCdelta into mitochondria and inhibited the CER-derived development of renal dysfunction. These results suggest that the CER-derived early translocation of PKCdelta into mitochondria probably leads to the enhanced production of free radicals through the mitochondrial respiratory chain during the development of the nephrotoxicity caused by CER. Understanding the role of PKCdelta in mitochondria may provide an important clue to the molecular mechanisms of mitochondrial production of reactive oxygen species and the free radical-induced renal failure in rats treated with CER.


Sujet(s)
Céfaloridine/pharmacologie , Radicaux libres/métabolisme , Cortex rénal/effets des médicaments et des substances chimiques , Maladies du rein/enzymologie , Mitochondries/effets des médicaments et des substances chimiques , Animaux , Cortex rénal/enzymologie , Maladies du rein/anatomopathologie , Mâle , Mitochondries/enzymologie , Inhibiteurs de protéines kinases/pharmacologie , Transport des protéines/effets des médicaments et des substances chimiques , Transport des protéines/physiologie , Rats , Rat Sprague-Dawley
6.
Toxicol Lett ; 143(2): 185-94, 2003 Jul 20.
Article de Anglais | MEDLINE | ID: mdl-12749822

RÉSUMÉ

We have previously reported that free radical-mediated injury induced by cephaloridine (CER) is enhanced by phorbol 12-myristate 13-acetate (PMA), a protein kinase C (PKC) activator, in rat renal cortical slices. We have also shown that PKC activation in mitochondria is involved in CER-induced nephrotoxicity in rats. We investigated the role of a downstream PKC pathway, a MEK/ERK pathway, in free radical-induced injury in rat renal cortical slices exposed to CER. Immediately after preparing slices from rat renal cortex, the slices were incubated in the medium containing MEK inhibitors. ERK1/2 activation was determined by Western blot analysis for phosphorylated ERK (pERK) 1/2 protein in nucleus fraction prepared from the slices exposed to CER. Prominently, CER caused not only increases in lipid peroxidation as an index of free radical generation and in LDH leakage as that of cell injury in the slices, but also marked activation of ERK1/2 in nucleus fraction. PD98059 and U0126, MEK1/2 inhibitors, significantly attenuated CER-induced increases in lipid peroxidation and LDH leakage in the slices. PD98059 also suppressed ERK1/2 activation in nucleus fraction prepared from the slices treated with CER. Inhibition of other MAP kinase pathways, p38 MAP kinase and c-Jun N-terminal kinase (JNK) had no effect on CER-induced increases in lipid peroxidation level and LDH leakage in the slices. The present results suggest that a MEK/ERK pathway down stream of a PKC pathway is probably involved in free radical-induced injury in rat renal cortical slices exposed to CER.


Sujet(s)
Céfaloridine/pharmacologie , Cortex rénal/effets des médicaments et des substances chimiques , Cortex rénal/anatomopathologie , Système de signalisation des MAP kinases/effets des médicaments et des substances chimiques , Mitogen-Activated Protein Kinases/métabolisme , Animaux , Antioxydants/pharmacologie , Antienzymes/pharmacologie , Régulation de l'expression des gènes , Techniques in vitro , Cortex rénal/enzymologie , Cortex rénal/métabolisme , Mâle , Mitogen-Activated Protein Kinase Kinases/antagonistes et inhibiteurs , Mitogen-Activated Protein Kinase Kinases/métabolisme , Mitogen-Activated Protein Kinases/antagonistes et inhibiteurs , Phénylènediamines/pharmacologie , Phosphorylation , Rats , Rat Sprague-Dawley
7.
Eur J Pharmacol ; 465(1-2): 1-7, 2003 Mar 28.
Article de Anglais | MEDLINE | ID: mdl-12650826

RÉSUMÉ

Cephalosporin antibiotics are thought to be excreted into the urine via organic anion transporters (OATs) and OAT can mediate nephrotoxicity by cephalosporins, particularly by cephaloridine. The purpose of this study was to elucidate the interaction of human-OAT2 and rat-OAT2 with cephalosporin antibiotics using proximal tubule cells stably expressing human-OAT2 and rat-OAT2. Human-OAT2 is localized to the basolateral side of the proximal tubule, whereas rat-OAT2 is localized to the apical side of the proximal tubule. Cephalosporins tested were cephalothin, cefoperazone, cefazolin, ceftriaxone, cephaloridine, cefotaxime, cefadroxil and cefamandole. These cephalosporins dose-dependently inhibited organic anion uptake mediated by human-OAT2 and rat-OAT2. There was no species difference observed for the effects of OAT2 with cephalosporins between human and rat transporters. Kinetic analysis revealed that the inhibitory effects for human-OAT2 were competitive. Cephaloridine significantly decreased the viability of cells stably expressing human-OAT2, human-OAT1, human-OAT3 and human-OAT4. The decreased viability of cells stably expressing human-OAT1, human-OAT3 and human-OAT4 but not human-OAT2 was reversed by probenecid. In conclusion, human-OAT2 interacts with cephalosporins, and thus, human-OAT2 may mediate the uptake of cephalosporins on the basolateral side of the proximal tubule. The interaction of human-OAT2 with cephalosporins was the weakest among the basolateral human-OATs tested. In addition, it is suggested that human-OATs mediate cephaloridine-induced nephrotoxicity.


Sujet(s)
Antibactériens/pharmacologie , Céphalosporines/pharmacologie , Transporteurs d'anions organiques sodium-indépendants/métabolisme , Animaux , Transport biologique/effets des médicaments et des substances chimiques , Céfadroxil/pharmacologie , Céfamandole/pharmacologie , Céfazoline/pharmacologie , Céfopérazone/pharmacologie , Céfotaxime/pharmacologie , Ceftriaxone/pharmacologie , Lignée cellulaire , Survie cellulaire/effets des médicaments et des substances chimiques , Céfaloridine/pharmacologie , Céfalotine/pharmacologie , Dinoprost/pharmacocinétique , Relation dose-effet des médicaments , Humains , Cinétique , Souris , Souris transgéniques , Transporteurs d'anions organiques sodium-indépendants/génétique , Probénécide/pharmacologie , Rats , Transfection , Uricosuriques/pharmacologie
8.
Life Sci ; 72(1): 49-57, 2002 Nov 22.
Article de Anglais | MEDLINE | ID: mdl-12409144

RÉSUMÉ

We reported previously that treatment of the pig kidney proximal tubular epithelial cell line LLC-PK(1) with cephaloridine (CLD) decreased the activity of cytochrome c oxidase in the mitochondria of the cells followed by increases in lipid peroxidation and cell necrosis. In this study, we investigated the effects of CLD on the activity of cytochrome c oxidase in mitochondria isolated from LLC-PK(1) cells and purified the enzyme from mitochondria of the rat renal cortex. The activity of cytochrome c oxidase in the isolated mitochondria from LLC-PK(1) cells was significantly decreased from 1 h after addition of 1 mM CLD. Other cephalosporin antibiotics, cefazolin and cefalotin, also decreased the activity of cytochrome c oxidase in the isolated mitochondria. The activity of cytochrome c oxidase purified from the mitochondria of the rat renal cortex was also decreased from 2 h after addition of 1 mM CLD in a non-competitive manner. These results suggest that the direct inhibition of cytochrome c oxidase activity in the mitochondrial electron transport chain by cephlosporins may result from the observed nephrotoxicity.


Sujet(s)
Antibactériens/pharmacologie , Céfaloridine/pharmacologie , Complexe IV de la chaîne respiratoire/métabolisme , Rein/effets des médicaments et des substances chimiques , Mitochondries/effets des médicaments et des substances chimiques , Animaux , Lignée cellulaire , Céphalosporines/pharmacologie , Relation dose-effet des médicaments , Systèmes de délivrance de médicaments , Complexe IV de la chaîne respiratoire/isolement et purification , Cellules épithéliales/effets des médicaments et des substances chimiques , Cellules épithéliales/enzymologie , Rein/cytologie , Rein/enzymologie , Cortex rénal/enzymologie , Cinétique , Mâle , Mitochondries/composition chimique , Mitochondries/enzymologie , Protéines mitochondriales/analyse , Rats , Rat Wistar
9.
Eur J Pharmacol ; 438(3): 137-42, 2002 Mar 08.
Article de Anglais | MEDLINE | ID: mdl-11909604

RÉSUMÉ

Cephalosporin antibiotics are thought to be excreted into the urine via organic anion transporters (OATs). The purpose of this study was to elucidate the interaction of human-OATs with various cephalosporin antibiotics, using proximal tubule cells stably expressing human-OAT1, human-OAT3 and human-OAT4. Human-OAT1 and human-OAT3 are localized to the basolateral side of the proximal tubule, whereas human-OAT4 is localized to the apical side. The cephalosporin antibiotics tested were cephalothin, cefoperazone, cefazolin, ceftriaxone, cephaloridine, cefotaxime, cefadroxil and cefamandole. All of these cephalosporin antibiotics significantly inhibited organic anion uptake mediated by human-OAT1, human-OAT3 and human-OAT4. Kinetic analysis revealed that these inhibitions were competitive. The inhibition constant (K(i)) values of cefoperazone, cefazolin, ceftriaxone and cephaloridine for human-OAT1 were much lower than those for human-OAT3 and human-OAT4, whereas the K(i) values of cephalothin and cefotaxime for human-OAT3 were much lower than those for human-OAT1 and human-OAT4. Human-OAT4 mediated the bidirectional transport of estrone sulfate, an optimal substrate for human-OAT4. These results suggest that human-OAT1, human-OAT3 and human-OAT4 interact with various cephalosporin antibiotics, and that human-OAT1 and human-OAT3 play a distinct role in the basolateral uptake of cephalosporin antibiotics. Since the K(i) value of cephaloridine for human-OAT4-mediated organic uptake was much higher than that for human-OAT1, the results indicate the possibility that human-OAT4 limits the efflux of cephaloridine, leading to the accumulation of cephaloridine and the induction of nephrotoxicity.


Sujet(s)
Céphalosporines/pharmacologie , Oestrone/analogues et dérivés , Transporteurs d'anions organiques/effets des médicaments et des substances chimiques , Animaux , Transport biologique/effets des médicaments et des substances chimiques , Céfadroxil/pharmacologie , Céfotaxime/pharmacologie , Ceftriaxone/pharmacologie , Lignée cellulaire , Céfaloridine/pharmacologie , Céfalotine/pharmacologie , Oestrone/pharmacocinétique , Humains , Cinétique , Polypeptide C de transport d'anions organiques , Souris , Souris transgéniques , Protéine-1 de transport d'anions organiques/effets des médicaments et des substances chimiques , Protéine-1 de transport d'anions organiques/génétique , Protéine-1 de transport d'anions organiques/physiologie , Transporteurs d'anions organiques/génétique , Transporteurs d'anions organiques/physiologie , Transporteurs d'anions organiques sodium-indépendants/effets des médicaments et des substances chimiques , Transporteurs d'anions organiques sodium-indépendants/génétique , Transporteurs d'anions organiques sodium-indépendants/physiologie , Tritium
10.
Infect Immun ; 70(1): 121-6, 2002 Jan.
Article de Anglais | MEDLINE | ID: mdl-11748172

RÉSUMÉ

OmpT and OmpU are pore-forming proteins of the outer membrane of Vibrio cholerae, a pathogen that colonizes the intestine and produces cholera. Expression of the ompU and ompT genes is under the regulation of ToxR, a transmembrane transcriptional activator that also controls expression of virulence factors. It was recently shown that bile stimulates the ToxR-mediated transcription of ompU and that ompU-expressing strains are more resistant to bile and anionic detergents than ompT-expressing cells. In order to further understand the role of the OmpT and OmpU porins in the ability of V. cholerae to survive and colonize the host intestine, we examined the outer membrane permeability of cells expressing only ompU or only ompT or both genes in the absence and in the presence of bile. By comparing various strains in terms of the rate of degradation of the beta-lactam antibiotic cephaloridine by the periplasmic beta-lactamase, we found that the permeation of the antibiotic through the outer membrane of OmpU-containing cells was slower than the permeation in OmpT-containing cells. In addition, the OmpU-mediated outer membrane permeability was not affected by external bile, while the OmpT-mediated antibiotic flux was reduced by bile in a concentration-dependent manner. Our results confirm that OmpT and OmpU provide a passageway for hydrophilic solutes through the outer membrane and demonstrate that bile might interfere with this traffic in OmpT-producing cells by functionally inhibiting the OmpT pore. The insensitivity of OmpU to bile may be due to its small pore size and may provide an explanation for the resistance of OmpU-producing cells to bile in vivo.


Sujet(s)
Adhésines bactériennes/métabolisme , Protéines de la membrane externe bactérienne/métabolisme , Bile/métabolisme , Porines/métabolisme , Vibrio cholerae/métabolisme , Adhésines bactériennes/physiologie , Animaux , Antibactériens/pharmacologie , Protéines de la membrane externe bactérienne/physiologie , Protéines bactériennes , Céfaloridine/pharmacologie , Porines/physiologie , Vibrio cholerae/effets des médicaments et des substances chimiques , Vibrio cholerae/physiologie
11.
Biochem Pharmacol ; 62(8): 1037-46, 2001 Oct 15.
Article de Anglais | MEDLINE | ID: mdl-11597572

RÉSUMÉ

Palmitoyl-CoA (Pal-CoA) lowered the respiratory control ratio (RCR), and induced mitochondrial membrane permeability transition (MPT) and cytochrome c (Cyt. c) release from isolated rat liver mitochondria. L-Carnitine suppressed the Pal-CoA-induced dysfunction, MPT, and Cyt. c release of isolated mitochondria. This suppression was inhibited by cephaloridine, an inhibitor of carnitine uptake into mitochondria. Cyclosporin A (CsA), an inhibitor of MPT, and BSA also suppressed the Pal-CoA-induced MPT. In the presence of inorganic phosphate (P(i)), Ca2+-induced MPT was suppressed by BSA, L-carnitine, and chlorpromazine, an inhibitor of phospholipase A2. In the presence of a low concentration of Ca2+, 3,3',5-triiodothyronine, long chain fatty acids, salicylic acid, and diclofenac induced MPT by a mechanism that was suppressed by BSA, L-carnitine, or chlorpromazine. During the incubation of mitochondria on ice, their respiratory competence decreased; L-carnitine and BSA also prevented this decrease. Mitochondrial depolarization in pheochromocytoma PC12 cells was induced by either serum deprivation or arachidonic acid by a mechanism that was suppressed by acetyl-L-carnitine. These results indicate that some MPTs may be regulated by fatty acid metabolism and that the Pal-CoA-induced MPT plays an important role in the induction of apoptosis.


Sujet(s)
Carnitine/pharmacologie , Acides gras/pharmacologie , Mitochondries du foie/effets des médicaments et des substances chimiques , Animaux , Vieillissement de la cellule/effets des médicaments et des substances chimiques , Céfaloridine/pharmacologie , Céphalosporines/pharmacologie , Chlorpromazine/pharmacologie , Ciclosporine/pharmacologie , Cytochromes de type c/métabolisme , Antagonistes de la dopamine/pharmacologie , Interactions médicamenteuses , Antienzymes/pharmacologie , Mitochondries du foie/physiologie , Gonflement mitochondrial/effets des médicaments et des substances chimiques , Cellules PC12 , Palmitoyl coenzyme A/pharmacologie , Perméabilité/effets des médicaments et des substances chimiques , Phosphorylation , Rats , Rat Wistar , Sérumalbumine bovine/pharmacologie
12.
J Microbiol Methods ; 47(2): 243-7, 2001 Nov.
Article de Anglais | MEDLINE | ID: mdl-11576688

RÉSUMÉ

Pseudomonas agar base supplemented with cephaloridine, fucidin, and cetrimide (CFC) was used to count Pseudomonas populations on fish. Both Enterobacteriaceae and Shewanella putrefaciens were able to grow on the CFC medium. Evaluation of the performance of CFC-selective for pseudomonads medium, on fish samples stored aerobically and under a modified atmosphere at 0, 10 and 20 degrees C was tested. The selectivity of the medium was affected by storage temperatures and the type of packaging of the fish samples. The selectivity of the medium diminished as the population increased and for samples stored at high temperature (20 degrees C) or under modified atmospheres. When designing adequate selectivity of a medium, interfering organisms should be taken into account, especially when the background flora tends to be more robust than the organisms to be counted or detected.


Sujet(s)
Céfaloridine/pharmacologie , Composés de cétrimonium/pharmacologie , Écosystème , Poissons/microbiologie , Pseudomonas/effets des médicaments et des substances chimiques , Pseudomonas/croissance et développement , Animaux , Bromure de cétrimonium , Numération de colonies microbiennes , Milieux de culture/composition chimique , Milieux de culture/pharmacologie , Enterobacteriaceae/effets des médicaments et des substances chimiques , Enterobacteriaceae/croissance et développement , Enterobacteriaceae/isolement et purification , Environnement contrôlé , Manipulation des aliments/méthodes , Microbiologie alimentaire , Conservation aliments/méthodes , Viande/microbiologie , Pseudomonas/isolement et purification , Shewanella/effets des médicaments et des substances chimiques , Shewanella/croissance et développement , Shewanella/isolement et purification , Spécificité du substrat , Température
13.
Am J Physiol Renal Physiol ; 281(2): F273-9, 2001 Aug.
Article de Anglais | MEDLINE | ID: mdl-11457718

RÉSUMÉ

We investigated expression of the Na(+)-L-carnitine cotransport system and its role in transport of tetraethylammonium in a kidney epithelial cell line, LLC-PK(1). L-Carnitine uptake in the LLC-PK(1) cells was markedly stimulated in the presence of Na(+). The uptake was saturable, with Michaelis constant and maximal uptake velocity values of 7.8 microM and 153.7 pmol x mg protein(-1) x 15 min(-1), respectively. Cationic drugs such as tetraethylammonium, cimetidine, and quinidine inhibited L-carnitine uptake. The basolateral-to-apical transport of [(14)C]tetraethylammonium was enhanced markedly in the presence of an H(+) gradient on the apical side at a pH of 5.9. Under the conditions in which Na(+)/L-carnitine cotransport activity was saturable by the addition of 100 microM L-carnitine to the apical-side medium, the basolateral-to-apical transcellular transport of [(14)C]tetraethylammonium was unaffected. These results suggested that the Na(+)-L-carnitine cotransporter is expressed in the apical membranes of LLC-PK(1) cells, and is not responsible for efflux of tetraethylammonium from the cells. Transport of tetraethylammonium appeared to be mediated predominantly by an H(+)/organic cation antiporter in the apical membranes.


Sujet(s)
Carnitine/métabolisme , Protéines de transport/métabolisme , Tubules contournés proximaux/métabolisme , Sodium/métabolisme , Tétraéthyl-ammonium/métabolisme , Animaux , Carnitine/pharmacologie , Cations/métabolisme , Lignée cellulaire , Polarité de la cellule , Céfaloridine/pharmacologie , Céphalosporines/pharmacologie , Cimétidine/pharmacologie , Antienzymes/pharmacologie , Cellules épithéliales/effets des médicaments et des substances chimiques , Cellules épithéliales/métabolisme , Concentration en ions d'hydrogène , Transport des ions/effets des médicaments et des substances chimiques , Tubules contournés proximaux/cytologie , Cinétique , Quinidine/pharmacologie , Suidae
14.
Jpn J Pharmacol ; 85(1): 54-9, 2001 Jan.
Article de Anglais | MEDLINE | ID: mdl-11243575

RÉSUMÉ

Intracellular signaling pathways of cAMP and protein kinase C (PKC) have been suggested to modulate the generation of free radicals. We investigated the effects of cAMP and phorbol myristate acetate (PMA), a PKC activator, on cephaloridine (CER)-induced renal cell injury, which has been reported to be due to the generation of free radicals. Incubation of rat renal cortical slices with CER resulted in increases in lipid peroxidation and lactate dehydrogenase (LDH) release and in decreases in gluconeogenesis and p-aminohippurate (PAH) accumulation in rat renal cortical slices, suggesting free radical-induced injury in slices exposed to CER. A derivative of cAMP ameliorated not only the increase in lipid peroxidation but also the renal cell damage induced by CER. This amelioration by a cAMP derivative of lipid peroxidation and renal cell damage caused by CER was blocked by KT 5720, a protein kinase A (PKA) inhibitor. Lipid peroxidation and the indices of cell injury were increased by PMA. PMA also enhanced CER-induced lipid peroxidation and cell damage in the slices. This enhancement by PMA of CER-induced injury was blocked by H-7, a PKC inhibitor. These results indicated that intracellular signaling pathways of cAMP and PKC modulate free radical-mediated nephrotoxicity induced by CER.


Sujet(s)
Carbazoles , AMP cyclique/métabolisme , Radicaux libres/métabolisme , Protéine kinase C/métabolisme , Transduction du signal/effets des médicaments et des substances chimiques , 5-(2-Méthyl-pipérazine-1-sulfonyl)isoquinoléine/pharmacologie , Animaux , Cancérogènes/pharmacologie , Céfaloridine/pharmacologie , Céphalosporines/pharmacologie , Antienzymes/pharmacologie , Radicaux libres/effets indésirables , Néoglucogenèse/effets des médicaments et des substances chimiques , Néoglucogenèse/physiologie , Techniques in vitro , Indoles/pharmacologie , Cortex rénal/traumatismes , Cortex rénal/métabolisme , L-Lactate dehydrogenase/métabolisme , Peroxydation lipidique/effets des médicaments et des substances chimiques , Peroxydation lipidique/physiologie , Mâle , Pyrroles/pharmacologie , Rats , Rat Sprague-Dawley , Transduction du signal/physiologie , 12-Myristate-13-acétate de phorbol/pharmacologie , Acide 4-amino-hippurique/métabolisme
15.
Antimicrob Agents Chemother ; 45(2): 616-20, 2001 Feb.
Article de Anglais | MEDLINE | ID: mdl-11158766

RÉSUMÉ

A cefotaxime-resistant, ceftazidime-susceptible Escherichia coli isolate was obtained from a patient with sepsis in 1997, from which a beta-lactamase with a pI of 8.1 was cloned. Cephaloridine and cefotaxime relative hydrolysis rates were 167 and 81, respectively (penicillin G rate = 100), whereas ceftazidime hydrolysis was not detected. The nucleotide sequence revealed a bla gene related to that coding for CTX-M-3. Despite 21 nucleotide substitutions, only 2 determined amino acid changes (Ala27Val and Arg38Gln). The amino acid sequence identity between this enzyme, designated CTX-M-10, and the chromosomal beta-lactamase of Kluyvera ascorbata was 81%.


Sujet(s)
Escherichia coli/enzymologie , Escherichia coli/génétique , bêta-Lactamases/composition chimique , bêta-Lactamases/génétique , Céfotaxime/métabolisme , Céfotaxime/pharmacologie , Céfaloridine/métabolisme , Céfaloridine/pharmacologie , Céphalosporines/métabolisme , Céphalosporines/pharmacologie , ADN bactérien/analyse , ADN bactérien/génétique , Résistance microbienne aux médicaments/génétique , Escherichia coli/effets des médicaments et des substances chimiques , Infections à Escherichia coli/microbiologie , Gènes bactériens/génétique , Humains , Cinétique , Tests de sensibilité microbienne , Données de séquences moléculaires
16.
J Bacteriol ; 183(1): 200-6, 2001 Jan.
Article de Anglais | MEDLINE | ID: mdl-11114917

RÉSUMÉ

Penicillin-binding protein 1b (PBP1b) is the major high-molecular-weight PBP in Escherichia coli. Although it is coded by a single gene, it is usually found as a mixture of three isoforms which vary with regard to the length of their N-terminal cytoplasmic tail. We show here that although the cytoplasmic tail seems to play no role in the dimerization of PBP1b, as was originally suspected, only the full-length protein is able to protect the cells against lysis when both PBP1a and PBP3 are inhibited by antibiotics. This suggests a specific role for the full-length PBP1b in the multienzyme peptidoglycan-synthesizing complex that cannot be fulfilled by either PBP1a or the shorter PBP1b proteins. Moreover, we have shown by alanine-stretch-scanning mutagenesis that (i) residues R(11) to G(13) are major determinants for correct translocation and folding of PBP1b and that (ii) the specific interactions involving the full-length PBP1b can be ascribed to the first six residues at the N-terminal end of the cytoplasmic domain. These results are discussed in terms of the interactions with other components of the murein-synthesizing complex.


Sujet(s)
Protéines bactériennes , Protéines de transport , Cytoplasme/enzymologie , Protéines Escherichia coli , Escherichia coli/enzymologie , Hexosyltransferases/composition chimique , Hexosyltransferases/métabolisme , Complexes multienzymatiques/composition chimique , Complexes multienzymatiques/métabolisme , Muramoyl-pentapeptide carboxypeptidase , Peptidoglycan glycosyltransferase , Peptidyl transferases/composition chimique , Peptidyl transferases/métabolisme , Serine-type D-Ala-D-Ala carboxypeptidase , Séquence d'acides aminés , Antibactériens/pharmacologie , Aztréonam/pharmacologie , Céfaloridine/pharmacologie , Céphalosporines/pharmacologie , Dimérisation , Escherichia coli/effets des médicaments et des substances chimiques , Escherichia coli/génétique , Escherichia coli/croissance et développement , Hexosyltransferases/génétique , Isoenzymes/composition chimique , Isoenzymes/génétique , Isoenzymes/métabolisme , Données de séquences moléculaires , Complexes multienzymatiques/génétique , Mutation , Protéines de liaison aux pénicillines , Peptidyl transferases/génétique
17.
Biochemistry ; 39(38): 11777-87, 2000 Sep 26.
Article de Anglais | MEDLINE | ID: mdl-10995246

RÉSUMÉ

Lipopolysaccharide (LPS), the primary lipid on the surface of Gram-negative bacteria, is thought to act as a permeability barrier, making the outer membrane relatively impermeable to hydrophobic antibiotics, detergents, and host proteins. Mutations in the LPS biosynthetic apparatus increase bacterial susceptibility to such agents. To determine how this increased susceptibility is mediated, we have correlated antibiotic susceptibilities of rough (antibiotic resistant) and deep rough (antibiotic susceptible) bacterial strains with antibiotic permeabilities and fluorescent probe binding kinetics for bilayers composed of LPS purified from the same strains. Bilayer permeabilities of two hydrophobic beta-lactam antibiotics were measured by encapsulating the appropriate beta-lactamases in large unilamellar vesicles. In the presence of MgCl(2), permeabilities of LPS bilayers from rough and deep rough bacteria were similar and significantly lower than those of bacterial phospholipids (BPL). Addition of BPL to the LPS bilayers increased their antibiotic permeability to approximately the level of the BPL bilayers. Binding rates of the fluorescent probe bis-aminonaphthylsulfonic acid (BANS) were 2 orders of magnitude slower for both rough and deep rough LPS bilayers compared to that of bilayers composed of BPL or mixtures of LPS and BPL. On the basis of these results and the observation that deep rough bacteria have higher levels of phospholipid on their surface than do rough bacteria (Kamio, Y., and Nikaido, H. (1976) Biochemistry 15, 2561-2569), we argue that the high susceptibility of deep rough bacteria is due to the presence of phospholipids on their surface. Experiments with phospholipid bilayers showed that the addition of PEG-lipids (containing covalently attached hydrophilic polymers) had little effect on permeability and binding rates, whereas the addition of cholesterol reduced permeability and slowed binding to levels approaching those of LPS. Therefore, we argue that the barrier provided by LPS is primarily due to its tight hydrocarbon chain packing (Snyder et al., (1999) Biochemistry 38, 10758-10767) rather than to its polysaccharide headgroup.


Sujet(s)
Antibactériens/pharmacocinétique , Perméabilité des membranes cellulaires , Escherichia coli/métabolisme , Colorants fluorescents/pharmacocinétique , Lipopolysaccharides/pharmacocinétique , Salmonella typhimurium/métabolisme , Antibactériens/composition chimique , Antibactériens/pharmacologie , Sites de fixation , Perméabilité des membranes cellulaires/effets des médicaments et des substances chimiques , Céfaloridine/pharmacocinétique , Céfaloridine/pharmacologie , Céphalosporines/pharmacocinétique , Céphalosporines/pharmacologie , Cholestérol/pharmacocinétique , Escherichia coli/effets des médicaments et des substances chimiques , Escherichia coli/croissance et développement , Colorants fluorescents/composition chimique , Double couche lipidique/pharmacocinétique , Lipopolysaccharides/composition chimique , Tests de sensibilité microbienne , Phosphatidylcholines/pharmacocinétique , Phospholipides/pharmacocinétique , Rhodamines/pharmacocinétique , Salmonella typhimurium/effets des médicaments et des substances chimiques , Salmonella typhimurium/croissance et développement , Sulfones/pharmacocinétique , Diffraction des rayons X , Résistance aux bêta-lactamines
18.
Toxicol Appl Pharmacol ; 167(2): 151-6, 2000 Sep 01.
Article de Anglais | MEDLINE | ID: mdl-10964766

RÉSUMÉ

To clarify the mechanism of cephalosporin nephrotoxicity, the effects of cephaloridine (CLD), a nephrotoxic cephalosporin antibiotic, on the mitochondria of the pig kidney proximal tubular epithelial cell line LLC-PK(1) were studied in culture. The activity of cytochrome c oxidase in the mitochondria of LLC-PK(1) cells was significantly decreased from 9 h after addition of 1.0 mM CLD to the cultured cells. These effects were dose-dependent and accompanied with a significant decrease in the ATP content in the cells, followed by marked morphological changes in the mitochondria. These alterations were observed in the treated cells before the increase in lipid peroxidation. The activities of NADH-cytochrome c reductase and succinate dehydrogenase in the mitochondria and NADPH-cytochrome P450 reductase, NADH-cytochrome b(5) reductase, and 7-ethoxycoumarin O-deethylase in the microsomes of the treated cells were not affected. Superoxide anion production by the mitochondria prepared from LLC-PK(1) cells or NADH-cytochrome c reductase was not affected by addition of CLD (1-10 mM), but adriamycin (0.1 mM) or paraquat (0.1 mM) significantly increased the superoxide anion production. These results suggested that the primary action of CLD is inhibition of cytochrome c oxidase activity in the mitochondrial electron transport chain, which decreases intracellular ATP content in renal tubular epithelial cells and that these effects of CLD are followed by increased lipid peroxidation and cellular injury.


Sujet(s)
Céfaloridine/pharmacologie , Céphalosporines/pharmacologie , Complexe IV de la chaîne respiratoire/antagonistes et inhibiteurs , Antienzymes/pharmacologie , Cellules épithéliales/effets des médicaments et des substances chimiques , Mitochondries/effets des médicaments et des substances chimiques , Animaux , Cellules cultivées , Doxorubicine/pharmacologie , Cellules épithéliales/cytologie , Cellules épithéliales/ultrastructure , Maladies du rein/induit chimiquement , Maladies du rein/métabolisme , Tubules contournés proximaux/cytologie , Tubules contournés proximaux/effets des médicaments et des substances chimiques , Peroxydation lipidique/effets des médicaments et des substances chimiques , Microsomes/effets des médicaments et des substances chimiques , Microsomes/enzymologie , Mitochondries/imagerie diagnostique , Mitochondries/enzymologie , Paraquat/pharmacologie , Suidae , Échographie
19.
Rev. cuba. med. trop ; 51(2)mayo-ago. 1999.
Article de Espagnol | CUMED | ID: cum-34320

RÉSUMÉ

Se reporta un caso de rinitis purulenta aguda por Streptococcus pneumoniae en un paciente VIH/sida, atendido en el Servicio de Hospitalización del Instituto de Medicina Tropical Pedro Kourí. Los hallazgos clínicos fueron fiebre, rinorrea purulenta severa, con toma del estado general. Se aisló Streptococcus pneumoniae por diagnóstico convencional y de avanzada. La prueba de susceptibilidad antimicrobiana resultó sensible a la cefaloridina, ampicilina, penicilina G y oxacilina. Recibió tratamiento con ampicilina 2 g diarios durante 10 d, el cuadro clínico mejoró con regresión total de los síntomas(AU)


Sujet(s)
Humains , Streptococcus pneumoniae , Rhinite , Benzylpénicilline/pharmacologie , Céfaloridine/pharmacologie , Ampicilline/pharmacologie , Séropositivité VIH , Séropositivité VIH/diagnostic , Séropositivité VIH/thérapie , Infections à pneumocoques/complications , Infections à pneumocoques/diagnostic , Infections à pneumocoques/thérapie
20.
Antimicrob Agents Chemother ; 42(12): 3163-8, 1998 Dec.
Article de Anglais | MEDLINE | ID: mdl-9835509

RÉSUMÉ

In contrast to most Staphylococcus aureus isolates in which the gene for staphylococcal beta-lactamase (blaZ) is plasmid borne, isolates typeable by group II bacteriophages frequently carry blaZ on the chromosome. Furthermore, the chromosomal gene encodes the type B variant of staphylococcal beta-lactamase for which the nucleotide and deduced amino acid sequences have not yet been reported. To better understand beta-lactamase production among phage group II staphylococci and the nature of the type B beta-lactamase, we determined the type and amount of enzyme produced by 24 phage group II isolates. Of these isolates, 1 did not produce beta-lactamase, 8 produced the type B enzyme, and 15 produced the type C enzyme. In all eight type B beta-lactamase-producing isolates, blaZ was located on the chromosome. This was in contrast to the type C beta-lactamase-producing isolates, in which blaZ was located on a 21-kb plasmid. The nucleotide sequence corresponding to the leader peptide and the N-terminal 85% of the mature exoenzyme form of type B S. aureus was determined. The deduced amino acid sequence revealed 3 residues in the leader peptide and 12 residues in the exoenzyme portion of the beta-lactamase that differ from the prototypic type A beta-lactamase sequence. These include the serine-to-asparagine change at residue 216 found in the kinetically similar type C enzyme, a threonine-to-lysine change at residue 128 close to the SDN loop (residues 130 to 132), and several substitutions not found in any of the other staphylococcal beta-lactamases. In summary, modern isolates of S. aureus typeable by group II phages produce type B or type C staphylococcal beta-lactamase. The type B gene resides on the chromosome and has a sequence that, when compared to the sequences of the other staphylococcal beta-lactamases, corresponds well with its kinetic properties.


Sujet(s)
Chromosomes de bactérie/métabolisme , Staphylococcus aureus/enzymologie , bêta-Lactamases/métabolisme , Lysotypie , Séquence nucléotidique , Technique de Southern , Céfaloridine/pharmacologie , Céphalosporines/pharmacologie , Chromosomes de bactérie/génétique , Milieux de culture , ADN bactérien/analyse , Données de séquences moléculaires , Pénicillines/pharmacologie , Plasmides , Staphylococcus aureus/génétique , Staphylococcus aureus/isolement et purification , bêta-Lactamases/génétique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...